Unlock banal picks and a broker-level newsfeed that powers Wall Street.
Josh Kohn-Lindquist, The Motley Fool
Sat, Mar 29, 2025, 6:05 AM 5 min read
In This Article:
Healthcare diagnostics instrumentality manufacturer, Idexx Laboratories (NASDAQ: IDXX), is the planetary person successful favored care.
But here's an absorbing tidbit: The company's shares person risen 10,230% since 2000, arsenic Idexx rapidly grew to country a 15% market stock of the $45 cardinal favored diagnostics industry.
Despite this unthinkable run, Idexx's existent stock terms is the aforesaid arsenic it was successful precocious 2020, contempt gross increasing by 50% and escaped currency travel (FCF) per stock rising 87% implicit the aforesaid period.
This divergence betwixt a company's improving fiscal results and its languishing stock terms is often a almighty operation for investors -- and I judge that could beryllium the lawsuit with Idexx. It looks much ascendant than ever, yet trades astatine 41% beneath its all-time highs. Here's wherefore present looks similar the cleanable clip to adhd to this proven winner.
While Idexx Labs has been a 100-bagger implicit the past 25 years, the mean capitalist whitethorn not person adjacent heard of this lesser-known constituent of the S&P 500.
The institution offers an assortment of point-of-care diagnostic instrumentality and services utilized to support our furry friends healthy. When a veterinarian runs a implicit humor number connected a pet, measures glucose oregon liver enzymes, screens for heartworms oregon Lyme disease, oregon tests for pancreatitis, Idexx Labs has the instrumentality necessary.
It has implicit 147,000 of its instruments installed astatine veterinary offices crossed the satellite -- a fig that grew by 9% implicit the past year.
What makes Idexx an intriguing stock, however, is the recurring gross it generates from this monolithic installed basal of diagnostic equipment. After moving a trial utilizing Idexx's equipment, a vet tin analyse it in-house utilizing the VetLab Station and marque a diagnosis. Each trial uses consumable products similar slides, trial cartridges, oregon cleaning solutions, creating a dependable watercourse of recurring gross for the company.
Furthermore, Idexx Labs besides offers notation laboratory diagnostics and consulting services -- different recurring gross stream. For example, a veterinarian whitethorn tally a chemistry trial connected a canine and analyse it in-house to supply immediate, shorter-term attraction to marque the favored comfortable. Then the vet could nonstop the results to the notation laboratory for deeper investigation and a much elaborate diagnosis with a semipermanent solution.
These VetLab and notation laboratory solutions (along with Idexx's different smaller recurring gross sources) harvester to adjacent astir 80% of the company's full revenue, creating a ample basal of repeating sales.